A double-blind randomized phase 3 clinical trial led by Dana-Farber Cancer Institute researchers and conducted across several hundred cancer centers in the U.S. tested the addition of high-dose ...

Want stronger bones, more defined muscles, and an immune system that's tough as nails? Vitamin D3 is the secret sauce.

New York, Sep 15 A team of US researchers on Sunday said that high-dose vitamin D3 does not provide benefit for patients suffering from metastatic colorectal cancer. A randomised phase 3 clinical ...

A potential benefit for high-dose vitamin D3 was observed for patients with left-sided disease (i.e., primary tumors that arise in the descending colon, sigmoid colon, or rectum) and requires ...

A team of US-based researchers has concluded that high-dose vitamin D3 does not provide any additional benefit for patients suffering from metastatic colorectal cancer. This conclusion was reached ...

The SOLARIS results suggest, however, that high-dose vitamin D3 cannot be recommended as a treatment for patients with untreated metastatic colon cancer. Funding: National Cancer Institute; Pharmavite ...

(MENAFN- IANS) New York, Sep 15 (IANS) A team of US researchers on Sunday said that high-dose vitamin D3 does not provide benefit for patients suffering from metastatic colorectal cancer.

Study title: SOLARIS (Alliance A021703): A multicenter double-blind phase III randomized clinical trial of vitamin D combined with standard chemotherapy plus bevacizumab in patients with ...